You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Plasma Thromboplastin Antecedent Levels in Patients Receiving Coumarin Anticoagulants and in Patients with Laennec's Cirrhosis. ∗

Experimental Biology and Medicine

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Research article

First published online October, 1961

Plasma Thromboplastin Antecedent Levels in Patients Receiving Coumarin Anticoagulants and in Patients with Laennec's Cirrhosis. ∗

Volume 108, Issue 1

https://doi.org/10.3181/00379727-108-26863

Abstract

Summary

1. Plasma thromboplastin antecedent (PTA) levels are normal in patients receiving Dicumarol, Coumadin, or phenylindanedione. 2. PTA levels are depressed in patients with Laennec's cirrhosis. Degree of depression parallels prothrombin time value.

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues